United Pharm (033270) — Working Capital to Net Assets Ratio
United Pharm (033270) has a Working Capital to Net Assets ratio of 48.6% as of December 2025. Working capital of ₩220.93 Billion (current assets of ₩268.68 Billion minus current liabilities of ₩47.75 Billion) is measured against net assets of ₩454.63 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 033270 equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
United Pharm Working Capital to Net Assets (2011–2025)
This chart shows how United Pharm's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 48.6%, reflecting working capital of ₩220.93 Billion against net assets of ₩454.63 Billion KRW. Check United Pharm tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for United Pharm (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for United Pharm from 2011 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 033270 company net worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 48.6% | ₩220.93 Billion | ₩454.63 Billion | ₩268.68 Billion | ₩47.75 Billion | ▲ +0.2 pp |
| 2024 | 48.4% | ₩196.56 Billion | ₩406.21 Billion | ₩244.75 Billion | ₩48.19 Billion | ▲ +2.9 pp |
| 2023 | 45.5% | ₩172.14 Billion | ₩378.68 Billion | ₩244.73 Billion | ₩72.59 Billion | ▼ -1.5 pp |
| 2022 | 46.9% | ₩158.51 Billion | ₩337.86 Billion | ₩224.39 Billion | ₩65.88 Billion | ▼ -0.8 pp |
| 2021 | 47.7% | ₩143.50 Billion | ₩300.71 Billion | ₩204.36 Billion | ₩60.85 Billion | ▲ +4.0 pp |
| 2020 | 43.7% | ₩121.13 Billion | ₩276.89 Billion | ₩180.92 Billion | ₩59.79 Billion | ▲ +2.3 pp |
| 2019 | 41.5% | ₩105.82 Billion | ₩255.10 Billion | ₩164.52 Billion | ₩58.70 Billion | ▲ +1.0 pp |
| 2018 | 40.4% | ₩92.38 Billion | ₩228.48 Billion | ₩152.45 Billion | ₩60.07 Billion | ▲ +1.9 pp |
| 2017 | 38.5% | ₩77.66 Billion | ₩201.68 Billion | ₩127.82 Billion | ₩50.16 Billion | ▼ -4.2 pp |
| 2016 | 42.7% | ₩75.75 Billion | ₩177.39 Billion | ₩115.39 Billion | ₩39.64 Billion | ▼ -8.6 pp |
| 2014 | 51.3% | ₩83.00 Billion | ₩161.83 Billion | ₩111.43 Billion | ₩28.43 Billion | ▲ +4.5 pp |
| 2013 | 46.8% | ₩66.17 Billion | ₩141.44 Billion | ₩92.83 Billion | ₩26.66 Billion | ▲ +2.9 pp |
| 2012 | 43.9% | ₩58.60 Billion | ₩133.48 Billion | ₩93.18 Billion | ₩34.58 Billion | ▲ +0.1 pp |
| 2011 | 43.8% | ₩49.51 Billion | ₩113.04 Billion | ₩87.95 Billion | ₩38.44 Billion | — |